Cardiokol is a privately-owned digital telehealth company that develops voice-based markers and methods for monitoring and screening heart rhythm disorders in large at-risk populations. We utilize proprietary technology that is implemented in speech platforms such as landlines, smart phones, smart-speakers and voice assistants. Cardiokol offers revolutionary low-cost, risk-free, long-term and age-friendly monitoring solutions, applicable for mass at-risk populations of older adults (65+).
Location: Israel, Center District, Hevel Modiin Regional Council
Employees: 11-50
Founded date: 2017
Investors 1
| Date | Name | Website |
| - | K2X | k2x.capita... |
Mentions in press and media 2
| Date | Title | Description |
| 30.11.2021 | Nine digital health pioneers to join Bayer’s G4A program | Photo: filadendron/Getty Images |
| 19.11.2021 | Bayer G4A welcomes 9 companies to its 2021 Digital Health Partnerships Program (Sponsored) | G4A is Bayer’s digital health partnerships and investments team that is dedicated to scaling digital health companies that are changing the experience of health and developing integrated digital health solutions. The team’s vision is to ens... |